Patent
The present invention generally relates to the field of probiotic bacteria. In particular it relates to methods for treating functional GI disorders comprising administering Bifidobacterium longum , such as Bifidobacterium longum ATCC BAA-999.
1. A method for the treatment of irritable bowel syndrome and anxiety, the method comprising:
administering to a patient suffering from the same a composition comprising Bifidobacterium longum ATCC BAA-999, wherein the composition is selected from the group consisting of a dietary supplement, a nutraceutical, a drink, and a medical composition.
2. The method of claim 1 , wherein the composition comprises at least one other type of food grade bacteria.
3. The method of claim 1 , wherein the composition comprises at least one prebiotic.
4. The method of claim 3 , wherein the prebiotic is selected from the group consisting of oligosaccharides, dietary fibers, and mixtures thereof.
5. The method of claim 1 , wherein at least 5% of Bifidobacterium longum ATCC BAA-999 cells are viable in the composition.
6. The method of claim 1 , wherein at least 80% of Bifidobacterium longum ATCC BAA-999 cells are non-replicating in the composition.
7. The method of claim 1 , wherein the composition comprises between 10 4 and 10 10 cells of Bifidobacterium longum ATCC BAA-999 per g dry weight of the composition.
8. The method of claim 1 , wherein the composition comprises between 10 2 and 10 8 cells of Bifidobacterium longum ATCC BAA-999 per g dry weight of the composition.
9. The method of claim 1 , wherein the composition comprises a protein source comprising hydrolyzed whey protein.
10. The method of claim 1 , wherein the composition is in powder form having a water activity of less than 0.2.
11. The method of claim 2 , wherein the at least one other type of food grade bacteria is selected from the group consisting of lactic acid bacteria, propionibacteria and mixtures thereof.